 | • レポートコード：MRC2-11QY05030 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウイルス性結膜炎治療薬のグローバル市場について調査・分析したレポートです。種類別（FST-100、APD-209）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウイルス性結膜炎治療薬の競争状況、市場シェア ・世界のウイルス性結膜炎治療薬市場：種類別市場規模 2015年-2020年（FST-100、APD-209） ・世界のウイルス性結膜炎治療薬市場：種類別市場規模予測 2021年-2026年（FST-100、APD-209） ・世界のウイルス性結膜炎治療薬市場：用途別市場規模 2015年-2020年（病院、ASC） ・世界のウイルス性結膜炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、ASC） ・北米のウイルス性結膜炎治療薬市場分析：米国、カナダ ・ヨーロッパのウイルス性結膜炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウイルス性結膜炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウイルス性結膜炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウイルス性結膜炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adenovir Pharma、Allergan、NanoViricides、Takeda、NovaBay Pharmaceuticals、Novartis、Panoptes Pharma、NicOx ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period.
The increasing investments from ophthalmic drug manufacturers for the development of efficient treatment for viral conjunctivitis, coupled with the increasing awareness among people and augmenting expenditure on healthcare, are accelerating the growth rate of this market significantly.
Market Analysis and Insights: Global Viral Conjunctivitis Drugs Market
The global Viral Conjunctivitis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Viral Conjunctivitis Drugs Scope and Market Size
Viral Conjunctivitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Conjunctivitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Adenovir Pharma
Allergan
NanoViricides
Takeda
NovaBay Pharmaceuticals
Novartis
Panoptes Pharma
NicOx
Market segment by Type, the product can be split into
FST-100
APD-209
Market segment by Application, split into
Hospitals
ASCs
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Conjunctivitis Drugs Revenue
1.4 Market by Type
1.4.1 Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 FST-100
1.4.3 APD-209
1.5 Market by Application
1.5.1 Global Viral Conjunctivitis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 ASCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Viral Conjunctivitis Drugs Market Perspective (2015-2026)
2.2 Global Viral Conjunctivitis Drugs Growth Trends by Regions
2.2.1 Viral Conjunctivitis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Conjunctivitis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Viral Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Conjunctivitis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Conjunctivitis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Conjunctivitis Drugs Players by Market Size
3.1.1 Global Top Viral Conjunctivitis Drugs Players by Revenue (2015-2020)
3.1.2 Global Viral Conjunctivitis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Conjunctivitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Conjunctivitis Drugs Market Concentration Ratio
3.2.1 Global Viral Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Conjunctivitis Drugs Revenue in 2019
3.3 Viral Conjunctivitis Drugs Key Players Head office and Area Served
3.4 Key Players Viral Conjunctivitis Drugs Product Solution and Service
3.5 Date of Enter into Viral Conjunctivitis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Viral Conjunctivitis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
5.2 Global Viral Conjunctivitis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Conjunctivitis Drugs Market Size (2015-2020)
6.2 Viral Conjunctivitis Drugs Key Players in North America (2019-2020)
6.3 North America Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
6.4 North America Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Conjunctivitis Drugs Market Size (2015-2020)
7.2 Viral Conjunctivitis Drugs Key Players in Europe (2019-2020)
7.3 Europe Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
7.4 Europe Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Viral Conjunctivitis Drugs Market Size (2015-2020)
8.2 Viral Conjunctivitis Drugs Key Players in China (2019-2020)
8.3 China Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
8.4 China Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Conjunctivitis Drugs Market Size (2015-2020)
9.2 Viral Conjunctivitis Drugs Key Players in Japan (2019-2020)
9.3 Japan Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
9.4 Japan Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Conjunctivitis Drugs Market Size (2015-2020)
10.2 Viral Conjunctivitis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Viral Conjunctivitis Drugs Market Size (2015-2020)
11.2 Viral Conjunctivitis Drugs Key Players in India (2019-2020)
11.3 India Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
11.4 India Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Conjunctivitis Drugs Market Size (2015-2020)
12.2 Viral Conjunctivitis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Conjunctivitis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Viral Conjunctivitis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Adenovir Pharma
13.1.1 Adenovir Pharma Company Details
13.1.2 Adenovir Pharma Business Overview
13.1.3 Adenovir Pharma Viral Conjunctivitis Drugs Introduction
13.1.4 Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020))
13.1.5 Adenovir Pharma Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Viral Conjunctivitis Drugs Introduction
13.2.4 Allergan Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 NanoViricides
13.3.1 NanoViricides Company Details
13.3.2 NanoViricides Business Overview
13.3.3 NanoViricides Viral Conjunctivitis Drugs Introduction
13.3.4 NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.3.5 NanoViricides Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Viral Conjunctivitis Drugs Introduction
13.4.4 Takeda Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 NovaBay Pharmaceuticals
13.5.1 NovaBay Pharmaceuticals Company Details
13.5.2 NovaBay Pharmaceuticals Business Overview
13.5.3 NovaBay Pharmaceuticals Viral Conjunctivitis Drugs Introduction
13.5.4 NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.5.5 NovaBay Pharmaceuticals Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Viral Conjunctivitis Drugs Introduction
13.6.4 Novartis Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Panoptes Pharma
13.7.1 Panoptes Pharma Company Details
13.7.2 Panoptes Pharma Business Overview
13.7.3 Panoptes Pharma Viral Conjunctivitis Drugs Introduction
13.7.4 Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.7.5 Panoptes Pharma Recent Development
13.8 NicOx
13.8.1 NicOx Company Details
13.8.2 NicOx Business Overview
13.8.3 NicOx Viral Conjunctivitis Drugs Introduction
13.8.4 NicOx Revenue in Viral Conjunctivitis Drugs Business (2015-2020)
13.8.5 NicOx Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Viral Conjunctivitis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Conjunctivitis Drugs Revenue
Table 3. Ranking of Global Top Viral Conjunctivitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Conjunctivitis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of FST-100
Table 6. Key Players of APD-209
Table 7. Global Viral Conjunctivitis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Viral Conjunctivitis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Viral Conjunctivitis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Viral Conjunctivitis Drugs Market Share by Regions (2015-2020)
Table 11. Global Viral Conjunctivitis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Viral Conjunctivitis Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Viral Conjunctivitis Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Viral Conjunctivitis Drugs Players
Table 18. Global Viral Conjunctivitis Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Viral Conjunctivitis Drugs Market Share by Players (2015-2020)
Table 20. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Conjunctivitis Drugs as of 2019)
Table 21. Global Viral Conjunctivitis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Conjunctivitis Drugs Product Solution and Service
Table 24. Date of Enter into Viral Conjunctivitis Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Viral Conjunctivitis Drugs Market Size Share by Type (2015-2020)
Table 28. Global Viral Conjunctivitis Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Viral Conjunctivitis Drugs Market Size Share by Application (2015-2020)
Table 30. Global Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Viral Conjunctivitis Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 34. North America Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 36. North America Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 40. Europe Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 42. Europe Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 46. China Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 48. China Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 52. Japan Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 54. Japan Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 58. Southeast Asia Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 64. India Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 66. India Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Viral Conjunctivitis Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Viral Conjunctivitis Drugs Market Share (2019-2020)
Table 70. Central & South America Viral Conjunctivitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Viral Conjunctivitis Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Viral Conjunctivitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Viral Conjunctivitis Drugs Market Share by Application (2015-2020)
Table 74. Adenovir Pharma Company Details
Table 75. Adenovir Pharma Business Overview
Table 76. Adenovir Pharma Product
Table 77. Adenovir Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 78. Adenovir Pharma Recent Development
Table 79. Allergan Company Details
Table 80. Allergan Business Overview
Table 81. Allergan Product
Table 82. Allergan Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 83. Allergan Recent Development
Table 84. NanoViricides Company Details
Table 85. NanoViricides Business Overview
Table 86. NanoViricides Product
Table 87. NanoViricides Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 88. NanoViricides Recent Development
Table 89. Takeda Company Details
Table 90. Takeda Business Overview
Table 91. Takeda Product
Table 92. Takeda Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 93. Takeda Recent Development
Table 94. NovaBay Pharmaceuticals Company Details
Table 95. NovaBay Pharmaceuticals Business Overview
Table 96. NovaBay Pharmaceuticals Product
Table 97. NovaBay Pharmaceuticals Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 98. NovaBay Pharmaceuticals Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Panoptes Pharma Company Details
Table 105. Panoptes Pharma Business Overview
Table 106. Panoptes Pharma Product
Table 107. Panoptes Pharma Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 108. Panoptes Pharma Recent Development
Table 109. NicOx Business Overview
Table 110. NicOx Product
Table 111. NicOx Company Details
Table 112. NicOx Revenue in Viral Conjunctivitis Drugs Business (2015-2020) (Million US$)
Table 113. NicOx Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Conjunctivitis Drugs Market Share by Type: 2020 VS 2026
Figure 2. FST-100 Features
Figure 3. APD-209 Features
Figure 4. Global Viral Conjunctivitis Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. ASCs Case Studies
Figure 7. Viral Conjunctivitis Drugs Report Years Considered
Figure 8. Global Viral Conjunctivitis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Viral Conjunctivitis Drugs Market Share by Regions: 2020 VS 2026
Figure 10. Global Viral Conjunctivitis Drugs Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Viral Conjunctivitis Drugs Market Share by Players in 2019
Figure 13. Global Top Viral Conjunctivitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Conjunctivitis Drugs as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Viral Conjunctivitis Drugs Revenue in 2019
Figure 15. North America Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Viral Conjunctivitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
ウイルス性結膜炎パイプライン薬剤の世界市場（～2026年） Market Analysis and Insights: Global Viral Conjunctivitis Pipeline Drugs Market The global Viral Conjunctivitis Pipeline Drugs market size is projected to reach US$ 51 million by 2026, from US$ 36 million in 2020, at a CAGR of 39.5%% during 2021-2026. Global Viral Conjunctivitis Pipeline Drugs Scope…- 結膜炎治療薬の世界市場（～2026年） Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in …
- 細菌性結膜炎薬の世界市場（～2026年） Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …
- 細菌性結膜炎治療の世界市場（～2026年） Bacterial conjunctivitis is a serious eye infection caused by several types of bacteria. The aforementioned figures clarify that it is one of the most common eye problems affecting people of all ages across the U.S. Such higher prevalence of the disease definitely prompts at increasing demand for ef…
- アレルギー性結膜炎の世界市場（～2026年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…